Exosomes in the Diagnosis of Neuropsychiatric Diseases: A Review

Song Wu,Xinmiao Shang,Meng Guo,Lei Su,Jun Wang

DOI: https://doi.org/10.3390/biology13060387

2024-05-29

Biology

Abstract:Exosomes are 30–150 nm small extracellular vesicles (sEVs) which are highly stable and encapsulated by a phospholipid bilayer. Exosomes contain proteins, lipids, RNAs (mRNAs, microRNAs/miRNAs, long non-coding RNAs/lncRNAs), and DNA of their parent cell. In pathological conditions, the composition of exosomes is altered, making exosomes a potential source of biomarkers for disease diagnosis. Exosomes can cross the blood–brain barrier (BBB), which is an advantage for using exosomes in the diagnosis of central nervous system (CNS) diseases. Neuropsychiatric diseases belong to the CNS diseases, and many potential diagnostic markers have been identified for neuropsychiatric diseases. Here, we review the potential diagnostic markers of exosomes in neuropsychiatric diseases and discuss the potential application of exosomal biomarkers in the early and accurate diagnosis of these diseases. Additionally, we outline the limitations and future directions of exosomes in the diagnosis of neuropsychiatric diseases.

biology

What problem does this paper attempt to address?

The main purpose of this paper is to explore the potential applications of exosomes in the diagnosis of neuropsychiatric disorders and to summarize the role of exosomes as biomarkers in the early diagnosis and precise treatment of these diseases.

Specifically, the paper attempts to address the following aspects:
1. **Characteristics of exosomes and their advantages in diagnosing central nervous system (CNS) diseases**: Exosomes are small vesicles with a diameter of 30-150 nanometers, highly stable, and capable of crossing the blood-brain barrier (BBB), making them potential tools for detecting CNS diseases.
2. **Diagnosis of neurodevelopmental disorders**: Biomarkers related to autism spectrum disorder (ASD) have been found in exosomes, including changes in synaptic vesicle-related genes and mitochondrial DNA (mtDNA).
3. **Diagnosis of mental and volitional disorders**: Particularly in schizophrenia (SCZ), changes in miRNAs related to apoptosis, oxidative stress, and insulin signaling pathways have been discovered.
4. **Diagnosis of mood disorders**: In patients with depression and bipolar disorder (BD), changes in miRNAs related to neural activity and the PI3K/AKT, fatty acid metabolism, cell adhesion, and Wnt signaling pathways have been identified.
5. **Diagnosis of demyelinating diseases**: Biomarkers related to multiple sclerosis (MS) have been found in exosomes, including MOG protein, FGF-2 related miRNAs, and immune system-related miRNAs.

Through these studies, the paper aims to improve the diagnostic accuracy of neuropsychiatric disorders and support the development of personalized clinical treatment strategies.